Prevalence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2021/2022 in Poland
Acta Biochimica Polonica · 2024
DOI: 10.3389/abp.2024.12289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica Polonica, 2024. Verfasst von Katarzyna Kondratiuk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Influenza Viruses and Respiratory Viruses, Department of Virology, National Institute of Public Health NIH-National Research Institute,…. Hauptthemen laut MEDLINE: Influenza, Human, Antibodies, Viral, Hemagglutinin Glycoproteins, Influenza Virus, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstwo Zdrowia.
Abstract (Originalsprache)
The aim of the study was to determine the level of anti-hemagglutinin antibodies in the serum of patients during the 2021/2022 epidemic season in Poland. A total of 700 sera samples were tested, divided according to the age of the patients into 7 age groups: 0–4 years of age, 5–9 years of age, 10–14 years of age, 15–25 years of age, 26–44 years of age, 45–64 years of age and ≥65 years of age, 100 samples were collected from each age group. Anti-hemagglutinin antibody levels was determined using the haemagglutination inhibition assay (OZHA). The results obtained confirm the presence of anti-hemagglutinin antibodies for the antigens A/Victoria/2570/2019 (H1N1) pdm09, A/Cambodia/e0826360/2020 (H3N2), B/Washington/02/2019 and B/Phuket/3073/2013 recommended by World Health Organization (WHO) for the 2021/2022 epidemic season. The analysis of the results shows differences in the levels of individual anti-hemagglutinin antibodies in the considered age groups. In view of very low percentage of the vaccinated population in Poland, which was 6.90% in the 2021/2022 epidemic season, the results obtained in the study would have to be interpreted as the immune system response in patients after a previous influenza virus infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Influenza Viruses and Respiratory Viruses, Department of Virology, National Institute of Public Health NIH-National Research Institute, Warsaw, Poland.
- Department of Population Health Monitoring and Analysis, National Institute of Public Health NIH-National Research Institute, Warsaw, Poland.
Förderung
- Ministerstwo Zdrowia
Zitieren
APA
Kondratiuk, K., Hallmann, E., Szymański, K., Łuniewska, K., Poznańska, A., & Brydak, L. B. (2024). Prevalence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2021/2022 in Poland. Acta Biochimica Polonica. https://doi.org/10.3389/abp.2024.12289
Vancouver
Kondratiuk K, Hallmann E, Szymański K, Łuniewska K, Poznańska A, Brydak LB. Prevalence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2021/2022 in Poland. Acta Biochimica Polonica. 2024. doi:10.3389/abp.2024.12289
BibTeX
@article{Kondratiuk2024,
author = {Kondratiuk, Katarzyna and Hallmann, Ewelina and Szymański, Karol and Łuniewska, Katarzyna and Poznańska, Anna and Brydak, Lidia B},
title = {Prevalence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2021/2022 in Poland},
journal = {Acta Biochimica Polonica},
year = {2024},
doi = {10.3389/abp.2024.12289}
}
EUVIMED